Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...
Jonathon Brown | 3 days ago |

Rick Rule's holiday gifts to grow wealth

The average Canadian will spend C$1478 this holiday season with 43 per cent of the budget spent with online platforms Rule likes the idea of gifting precious metals and company shares as an alternative to traditional Christmas gifts “Philanthropy with a...
Coreena Robertson | December 4, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

'Coin Stories' host Natalie Brunell shares Bitcoin basics and tips

Check out the above video for Bitcoin Basics with “Coin Stories” podcast host and Bitcoin expert Natalie Brunell . In this must-watch interview, Brunell breaks down the basics of Bitcoin saying, “anyone can learn” and tha...
Coreena Robertson | May 2, 2024 |

What is green steel and why is this iron project so attractive?

The following is a transcription of the above video, and The Market Online has edited it for clarity . The critical mineral exploration and development company Strategic Resources (TSXV:SR) continues to focus on its high-purity iron and vanadium projects in Canada...
Brieanna McCutcheon | March 26, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Rich TV Live's Stocks to Watch this week (March 15, 2024)

Richard De Sousa of the Rich TV Live podcast serves up his latest Stocks to Watch, exclusively for Stockhouse . De Sousa offers some tips on capitalizing on the Bitcoin frenzy, suggests some AI plays, expects big things from a lithium stock and more in this week&Cl...
Rich TV Live | March 15, 2024 |

Buzz on the Bullboards: Who is shining through the market slump?

The market story this week has been less impressive on both sides of the border than what we saw in the week where February turned to March. Recent losses and flatline trading have negated Wall Street’s previous record-setting run where major U.S. indices ...
Jonathon Brown | March 7, 2024 |

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...
Jonathon Brown | January 25, 2024 |

Buzz on the Bullboards: Tracking Bombardier’s path, Tilray’s growth

This year began on a confusing path for investors as sectors struggle under greater inflation costs and hopes of an imminent interest rate cut fade. A few weeks later in 2024, we are starting to see a clearer picture of where many companies are headed this year. M...
Jonathon Brown | January 18, 2024 |
1 2 3 4 5 6 7 8 9 10 ...